ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Big success and even bigger failure for Daiichi Sankyo's experimental therapy
July 04, 2017Daiichi Sankyo has been hit with mixed news this week regarding its experimental therapy mirogabalin. The drug posted trial success in treating patients with post-herpetic neuralgia by hitting its primary endpoint, yet failed to hit its target in a trial
Pharma Sources Insight January 2025
